Drug data last refreshed 22h ago · AI intelligence enriched 2w ago
Xylocaine with Epinephrine is a local anesthetic injectable combining lidocaine hydrochloride and epinephrine bitartrate, approved since 1948. It is used for infiltration anesthesia, nerve blocks, and topical anesthesia in surgical and dental procedures. The epinephrine component causes vasoconstriction, prolonging lidocaine's duration of action and reducing systemic toxicity.
As LOE approaches, the brand team will transition from growth optimization to lifecycle extension and cost management strategies.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on Xylocaine with Epinephrine offers exposure to mature product lifecycle management, generic defense strategies, and healthcare cost pressures in hospital and surgical settings. This is a defensive, non-growth portfolio role suited for professionals focused on operational excellence and value demonstration rather than innovation.
Worked on XYLOCAINE W/ EPINEPHRINE at Fresenius Kabi? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/mo